The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

@inproceedings{Varbobitis2016TheAO,
  title={The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy},
  author={Ioannis C Varbobitis and G V Papatheodoridis},
  booktitle={Clinical and molecular hepatology},
  year={2016}
}
Hepatocellular carcinoma (HCC) is a primary concern for patients with chronic hepatitis B (CHB). Antiviral therapy has been reasonably the focus of interest for HCC prevention, with most studies reporting on the role of the chronologically preceding agents, interferon-alfa and lamivudine. The impact of interferon-alfa on the incidence of HCC is clearer in Asian patients and those with compensated cirrhosis, as several meta-analyses have consistently shown HCC risk reduction, compared to… CONTINUE READING
8 Citations
49 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 49 references

Associa - tion between level of fibrosis , rather than antiviral regimen , and outcomes of patients with chronic hepatitis B

  • HS Kim, BK Kim, SU Kim, JY Park, DY Kim, KJ Song
  • Clin Gastroenterol Hepatol
  • 2016

Similar Papers

Loading similar papers…